Literature DB >> 21576599

Cholesterol 25-hydroxylation activity of CYP3A.

Akira Honda1, Teruo Miyazaki, Tadashi Ikegami, Junichi Iwamoto, Tomomi Maeda, Takeshi Hirayama, Yoshifumi Saito, Tamio Teramoto, Yasushi Matsuzaki.   

Abstract

To date, many studies have been conducted using 25-hydroxycholesterol, which is a potent regulator of lipid metabolism. However, the origins of this oxysterol have not been entirely elucidated. Cholesterol 25-hydroxylase is one of the enzymes responsible for the metabolism of 25-hydroxycholesterol, but the expression of this enzyme is very low in humans. This oxysterol is also synthesized by sterol 27-hydroxylase (CYP27A1) and cholesterol 24-hydroxylase(CYP46A1), but it is only a minor product of these enzymes. We now report that CYP3A synthesizes a significant amount of 25-hydroxycholesterol and may participate in the regulation of lipid metabolism. Induction of CYP3A by pregnenolone-16α-carbonitrile caused the accumulation of 25-hydroxycholesterol in a cell line derived from mouse liver. Furthermore, treatment of the cells with troleandomycin, a specific inhibitor of CYP3A, significantly reduced cellular 25-hydroxycholesterol concentrations. In cells that overexpressed human recombinant CYP3A4, the activity of cholesterol 25-hydroxylation was found to be higher than that of cholesterol 4β-hydroxylation, a known marker activity of CYP3A4. In addition, 25-hydroxycholesterol concentrations in normal human sera correlated positively with the levels of 4β-hydroxycholesterol (r = 0.650, P < 0.0001, n = 78), but did not significantly correlate with the levels of 27-hydroxycholesterol or 24S-hydroxycholesterol. These results demonstrate the significance of CYP3A on the production of 25-hydroxycholesterol.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576599      PMCID: PMC3137016          DOI: 10.1194/jlr.M014084

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  36 in total

1.  Highly sensitive and specific analysis of sterol profiles in biological samples by HPLC-ESI-MS/MS.

Authors:  Akira Honda; Teruo Miyazaki; Tadashi Ikegami; Junichi Iwamoto; Kouwa Yamashita; Mitsuteru Numazawa; Yasushi Matsuzaki
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-17       Impact factor: 4.292

2.  Disruption of the oxysterol 7alpha-hydroxylase gene in mice.

Authors:  J Li-Hawkins; E G Lund; S D Turley; D W Russell
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

3.  Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis.

Authors:  A Honda; G Salen; Y Matsuzaki; A K Batta; G Xu; E Leitersdorf; G S Tint; S K Erickson; N Tanaka; S Shefer
Journal:  J Biol Chem       Date:  2001-07-13       Impact factor: 5.157

4.  Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4.

Authors:  K Bodin; L Bretillon; Y Aden; L Bertilsson; U Broomé; C Einarsson; U Diczfalusy
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

5.  Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.

Authors:  A Honda; G Salen; Y Matsuzaki; A K Batta; G Xu; E Leitersdorf; G S Tint; S K Erickson; N Tanaka; S Shefer
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

6.  Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding.

Authors:  J J Repa; E G Lund; J D Horton; E Leitersdorf; D W Russell; J M Dietschy; S D Turley
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

Review 7.  Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor.

Authors:  Steven A Kliewer; Timothy M Willson
Journal:  J Lipid Res       Date:  2002-03       Impact factor: 5.922

8.  Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS.

Authors:  Akira Honda; Kouwa Yamashita; Takashi Hara; Tadashi Ikegami; Teruo Miyazaki; Mutsumi Shirai; Guorong Xu; Mitsuteru Numazawa; Yasushi Matsuzaki
Journal:  J Lipid Res       Date:  2008-09-24       Impact factor: 5.922

9.  Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide.

Authors:  Ulf Diczfalusy; Katarina E Olofsson; Ann-Margreth Carlsson; Mei Gong; Douglas T Golenbock; Olav Rooyackers; Urban Fläring; Harry Björkbacka
Journal:  J Lipid Res       Date:  2009-06-05       Impact factor: 5.922

10.  25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production.

Authors:  David R Bauman; Andrew D Bitmansour; Jeffrey G McDonald; Bonne M Thompson; Guosheng Liang; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

View more
  40 in total

1.  Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice.

Authors:  Shin-Ichiro Nitta; Mari Hashimoto; Yasuhiro Kazuki; Shoko Takehara; Hiraku Suzuki; Mitsuo Oshimura; Hidetaka Akita; Kan Chiba; Kaoru Kobayashi
Journal:  AAPS J       Date:  2018-04-09       Impact factor: 4.009

2.  Still another activity by the highly promiscuous enzyme CYP3A4: 25-hydroxylation of cholesterol.

Authors:  Ulf Diczfalusy; Ingemar Björkhem
Journal:  J Lipid Res       Date:  2011-06-07       Impact factor: 5.922

3.  Tocotrienol attenuates triglyceride accumulation in HepG2 cells and F344 rats.

Authors:  Gregor Carpentero Burdeos; Kiyotaka Nakagawa; Fumiko Kimura; Teruo Miyazawa
Journal:  Lipids       Date:  2012-02-26       Impact factor: 1.880

Review 4.  SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.

Authors:  Hitoshi Shimano; Ryuichiro Sato
Journal:  Nat Rev Endocrinol       Date:  2017-08-29       Impact factor: 43.330

5.  25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism.

Authors:  Ying Liu; Zhuo Wei; Xingzhe Ma; Xiaoxiao Yang; Yuanli Chen; Lei Sun; Chuanrui Ma; Qing R Miao; David P Hajjar; Jihong Han; Yajun Duan
Journal:  J Lipid Res       Date:  2018-01-03       Impact factor: 5.922

6.  Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRβ1-governed pathway.

Authors:  Inna Astapova; Preeti Ramadoss; Ricardo H Costa-e-Sousa; Felix Ye; Kaila A Holtz; Yingxia Li; Michele W Niepel; David E Cohen; Anthony N Hollenberg
Journal:  J Clin Invest       Date:  2014-04-08       Impact factor: 14.808

7.  The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity.

Authors:  Janne Hukkanen; Johanna Puurunen; Tuulia Hyötyläinen; Markku J Savolainen; Aimo Ruokonen; Laure Morin-Papunen; Matej Orešič; Terhi Piltonen; Juha S Tapanainen
Journal:  Br J Clin Pharmacol       Date:  2015-07-22       Impact factor: 4.335

8.  Fish oil and indomethacin in combination potently reduce dyslipidemia and hepatic steatosis in LDLR(-/-) mice.

Authors:  Ganesan Murali; Ginger L Milne; Corey D Webb; Ann B Stewart; Ryan P McMillan; Brandon C Lyle; Matthew W Hulver; Viswanathan Saraswathi
Journal:  J Lipid Res       Date:  2012-07-29       Impact factor: 5.922

9.  Knockout of mouse Cyp3a gene enhances synthesis of cholesterol and bile acid in the liver.

Authors:  Mari Hashimoto; Kaoru Kobayashi; Mio Watanabe; Yasuhiro Kazuki; Shoko Takehara; Asumi Inaba; Shin-Ichiro Nitta; Naoto Senda; Mitsuo Oshimura; Kan Chiba
Journal:  J Lipid Res       Date:  2013-05-24       Impact factor: 5.922

10.  Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease.

Authors:  Tadashi Ikegami; Hideyuki Hyogo; Akira Honda; Teruo Miyazaki; Katsutoshi Tokushige; Etsuko Hashimoto; Kazuo Inui; Yasushi Matsuzaki; Susumu Tazuma
Journal:  J Gastroenterol       Date:  2012-05-09       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.